Research Funded by Box Rallies

Featured Research

Professor Gottlieb and his colleagues are conducting the first ever trial in humans to test immune cells (lymphocytes) that have been generated in the laboratory to fight fungus and are being given to patients with serious invasive fungal infections.

Explore Research

Developing Better Targeted Treatments for Adults with Hard-to-Treat Blood Cancer (B -ALL)

Developing inhibitors of the LMO4 oncoprotein

Developing less toxic treatment approaches for childhood brain cancer

Dual targeting of oncogenic cofactors MYC and histone deacetylase in high-risk childhood brain tumours

EAGLE FM Study: EvaluAtion of Groin Lymphadenectomy Extent For metastatic Melanoma

Effects of increased colonic butyrate on inherited colon cancer

Engineering childhood cancer for precision medicine

Evaluating new immunotherapies targeting the FAT1 cadherin in high risk leukaemia

Exploiting a new epigenetic regulatory mechanism for sustaining leukaemia-initiating activity

Finding new treatment targets for advanced melanoma

Finding new ways to treat liver cancer

Functional characterisation of the putative tumour suppressor gene MCC in colorectal cancer

Gene modified T cells expressing a chimeric antigen receptor for a kappa light chain antigen to treat multiple myeloma

Harnessing androgen-mediated viral mimicry to improve immunotherapy in prostate cancer

HCC Outcomes mitigation and disease Prevention through Clinical Partnerships (HOPE)

Ibudilast as a treatment for chemotherapy-induced peripheral neuropathies and cognitive impairments

Identification and targeting of a new subtype of estrogen receptor breast positive breast cancer

Identifying the drivers of stomach cancer to find more effective treatments